Prevencio announced the culminative presentation of patient data demonstrating that its artificial intelligence (AI)-driven HART ® blood tests are highly accurate in a broad range of patients, including those with diabetes, chronic kidney disease, hypertension, obesity, coronary heart disease, heart failure, chronic total occlusion (CTO) of the heart arteries, and Kawasaki disease. The HART platform is disease agnostic and may be used to develop diagnostics beyond